2-Hexaprenyl-6-methoxy-1,4-benzoquinol



Compound IDCDAMM01122
Common name2-Hexaprenyl-6-methoxy-1,4-benzoquinol
IUPAC name2-(3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl)-6-methoxybenzene-1,4-diol
Molecular formulaC37H56O3

Experimental data

Retention time15.96
Adduct[M+K]+
Actual mz587.394
Theoretical mz587.386
Error13.69
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.5756

Identifiers and class information

Inchi keyZAGWHOPYPMUKOK-CGIMVRETSA-N
SmilesOC=1C=C(OC)C(O)=C(C1)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)10
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)20
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)548.848
Computed dipole moment(dipole)3.821
Total solvent accessible surface area (SASA)1151.93
Hydrophobic component of SASA (FOSA)942.191
Hydrophilic component of SASA (FISA)95.327
Pie component of the SASA (PISA)114.41
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2105.15
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)2.25
Free energy of solvation of dipole (dip^2/V)0.0069338
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0027623
Globularity descriptor (glob)0.689596
Predicted polarizability in cubic angstroms (QPpolrz)66.345
Predicted hexadecane/gas partition coefficient (QPlogPC16)21.027
Predicted octanol/gas partition coefficient (QPlogPoct)25.247
Predicted water/gas partition coefficient (QPlogPw)4.652
Predicted octanol/water partition coefficient (QPlogPo/w)10.93
Predicted aqueous solubility (QPlogS)-13.085
Conformation-independent predicted aqueous solubility (CIQPlogS)-9.775
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.1
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1235.7
Predicted brain/blood partition coefficient (QPlogBB)-1.978
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)621.867
Predicted skin permeability, log Kp (QPlogKp)-0.953
PM3 calculated ionization potential (IP(ev))8.488
PM3 calculated electron affinity (EA(eV))-0.22
Number of likely metabolic reactions (#metab)21
Prediction of binding to human serum albumin (QPlogKhsa)3.028
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)50.949
Number of nitrogen and oxygen atoms (#NandO)3
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P48449LSSLanosterol synthaseT56175SEA
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SEA
Q14534SQLESqualene monooxygenase (by homology)T93344SEA
P49356FNTBFarnesyl protein transferaseT13127SEA
P12268IMPDH2Inosine-5'-monophosphate dehydrogenase 2T89360SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P49356FNTBFarnesyl protein transferaseT13127SEA
O95749GGPS1GeranyltranstransferaseT86528SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T56175DI0035Arterial occlusive disease[ICD-11: BD40]P48449LSS
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T93344DI0118Dermatophytosis[ICD-11: 1F28]Q14534SQLE
T93344DI0385Skin fungal infection disorder[ICD-11: EA60]Q14534SQLE
T13127DI0342Premature ageing appearance[ICD-11: LD2B]P49356FNTB
T89360DI0413Transplant rejection[ICD-11: NE84]P12268IMPDH2
T13127DI0342Premature ageing appearance[ICD-11: LD2B]P49356FNTB
T86528DI0057Bone paget disease[ICD-11: FB85]O95749GGPS1
T86528DI0237Low bone mass disorder[ICD-11: FB83]O95749GGPS1
T86528DI0267Mineral excesses[ICD-11: 5B91]O95749GGPS1
T86528DI0281Musculoskeletal disorder[ICD-11: FA00-FC0Z]O95749GGPS1

Copyright © 2025